Bioniche is poised for a new level of growth, with an expanded global presence, and a portfolio of products and technologies in development that promises to have a profound impact on the converging world of human and animal health. Effective therapies for bladder cancer and potentially other cancers; a cattle vaccine to help prevent E. coli O157:H7 infection; technologies to improve reproduction and potentially replace the use of antibiotics in livestock: these are key areas of strategic focus for Bioniche.
www.vetoquinolusa.com
Gene Hill
Vetoquinol USA
Ph: (352) 584-7483
Fax: (817) 529-7506
Click here to Email
Back to the Educational Partners page